Entrada Therapeutics Inc (TRDA)
18.15
-0.89
(-4.67%)
USD |
NASDAQ |
Nov 15, 12:32
Entrada Therapeutics Net Income (TTM): 54.95M for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 54.95M |
| June 30, 2024 | 104.44M |
| March 31, 2024 | 23.48M |
| December 31, 2023 | -6.685M |
| September 30, 2023 | -21.77M |
| June 30, 2023 | -82.37M |
| March 31, 2023 | -79.62M |
| Date | Value |
|---|---|
| December 31, 2022 | -94.62M |
| September 30, 2022 | -88.43M |
| June 30, 2022 | -77.73M |
| March 31, 2022 | -64.45M |
| December 31, 2021 | -51.16M |
| September 30, 2021 | -41.38M |
| June 30, 2021 | -33.94M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-94.62M
Minimum
Dec 2022
104.44M
Maximum
Jun 2024
-32.81M
Average
-46.27M
Median
Net Income (TTM) Benchmarks
| Fulcrum Therapeutics Inc | -20.23M |
| Catalyst Pharmaceuticals Inc | 142.80M |
| Vertex Pharmaceuticals Inc | -479.80M |
| Assembly Biosciences Inc | -45.61M |
| Sarepta Therapeutics Inc | 121.84M |